{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Seattle&page=62&state=Washington", "query": { "state": "Washington", "city": "Seattle", "page": 62 }, "page_size": 10 }, "pagination": { "page": 62, "page_size": 10, "total_count": 11419, "total_pages": 1142, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Seattle&page=63&state=Washington&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?city=Seattle&page=61&state=Washington&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T13:47:58.737Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03918447", "title": "A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Autosomal Dominant Polycystic Kidney", "ADPKD" ], "interventions": [ { "name": "Bardoxolone methyl oral capsule", "type": "DRUG" }, { "name": "Placebo oral capsule", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Biogen", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "12 Years to 70 Years" }, "enrollment_count": 667, "start_date": "2019-05-29", "completion_date": "2023-08-08", "has_results": true, "last_update_posted_date": "2025-06-03", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 83, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Huntsville, Alabama + 69 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Mesa", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT03918447" }, { "nct_id": "NCT03595176", "title": "Disrupt CAD III With the Shockwave Coronary IVL System", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Coronary Artery Disease", "Myocardial Infarction" ], "interventions": [ { "name": "Lithotripsy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Shockwave Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 431, "start_date": "2019-01-09", "completion_date": "2022-04-10", "has_results": true, "last_update_posted_date": "2023-05-19", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 39, "location_summary": "Scottsdale, Arizona • La Jolla, California • Orange, California + 32 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Palo Alto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03595176" }, { "nct_id": "NCT02787304", "title": "Volixibat (SHP626) in the Treatment of Adults With Nonalcoholic Steatohepatitis (NASH)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Alcoholic Steatohepatitis" ], "interventions": [ { "name": "SHP626", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mirum Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 197, "start_date": "2016-10-24", "completion_date": "2018-07-27", "has_results": true, "last_update_posted_date": "2019-11-25", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 49, "location_summary": "Coronado, California • Fresno, California • Los Angeles, California + 42 more", "locations": [ { "city": "Coronado", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Pasadena", "state": "California" }, { "city": "Rialto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02787304" }, { "nct_id": "NCT01649284", "title": "Afatinib Expanded Access Program", "overall_status": "APPROVED_FOR_MARKETING", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "afatinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": null, "start_date": "2012-07", "completion_date": "2014-03", "has_results": false, "last_update_posted_date": "2016-11-30", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 66, "location_summary": "Mobile, Alabama • Goodyear, Arizona • Hot Springs, Arkansas + 59 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" }, { "city": "Burbank", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01649284" }, { "nct_id": "NCT04188548", "title": "A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Breast Cancer", "Advanced Breast Cancer", "Metastatic Breast Cancer", "Endometrial Cancer" ], "interventions": [ { "name": "LY3484356", "type": "DRUG" }, { "name": "Abemaciclib", "type": "DRUG" }, { "name": "Everolimus", "type": "DRUG" }, { "name": "Alpelisib", "type": "DRUG" }, { "name": "Trastuzumab", "type": "DRUG" }, { "name": "Aromatase Inhibitor (AI)", "type": "DRUG" }, { "name": "Pertuzumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 379, "start_date": "2019-12-10", "completion_date": "2027-12", "has_results": false, "last_update_posted_date": "2026-06-22", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 42, "location_summary": "Gilbert, Arizona • Phoenix, Arizona • Springdale, Arkansas + 31 more", "locations": [ { "city": "Gilbert", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Springdale", "state": "Arkansas" }, { "city": "Beverly Hills", "state": "California" }, { "city": "Orange", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04188548" }, { "nct_id": "NCT04745026", "title": "Trial to Investigate the Safety and Efficacy of Cannabidiol Oral Solution (GWP42003-P; CBD-OS) in Children and Adolescents With Autism Spectrum Disorder", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Autism Spectrum Disorder" ], "interventions": [ { "name": "GWP42003-P", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Jazz Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 103, "start_date": "2021-05-31", "completion_date": "2023-12-21", "has_results": true, "last_update_posted_date": "2025-03-30", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 12, "location_summary": "Phoenix, Arizona • La Jolla, California • Los Angeles, California + 9 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Orlando", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT04745026" }, { "nct_id": "NCT04146376", "title": "Von Willebrand Factor in Pregnancy (VIP) Study", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Von Willebrand Diseases" ], "interventions": [ { "name": "Use of a postpartum diary and additional blood draws.", "type": "OTHER" }, { "name": "VWF replacement therapy with Wilate", "type": "DRUG" }, { "name": "Tranexamic acid", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 110, "start_date": "2019-10-12", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-12-18", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 11, "location_summary": "Aurora, Colorado • New Haven, Connecticut • Miami, Florida + 8 more", "locations": [ { "city": "Aurora", "state": "Colorado" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Miami", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Peoria", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04146376" }, { "nct_id": "NCT00112489", "title": "Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoma" ], "interventions": [ { "name": "carboplatin", "type": "DRUG" }, { "name": "paclitaxel", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gynecologic Oncology Group", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "FEMALE", "summary": "18 Years to 120 Years · Female only" }, "enrollment_count": 55, "start_date": "2005-05", "completion_date": null, "has_results": true, "last_update_posted_date": "2018-09-25", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 99, "location_summary": "Birmingham, Alabama • Los Angeles, California • New Britain, Connecticut + 73 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "New Britain", "state": "Connecticut" }, { "city": "Lewes", "state": "Delaware" }, { "city": "Newark", "state": "Delaware" } ], "official_url": "https://clinicaltrials.gov/study/NCT00112489" }, { "nct_id": "NCT01147874", "title": "Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Psoriasis", "Psoriatic Arthritis" ], "interventions": [ { "name": "lab draws and imaging", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1013, "start_date": "2010-08", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2012-06-21", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 6, "location_summary": "Dallas, Texas • Houston, Texas • Webster, Texas + 1 more", "locations": [ { "city": "Dallas", "state": "Texas" }, { "city": "Dallas", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Houston", "state": "Texas" }, { "city": "Webster", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01147874" }, { "nct_id": "NCT01723943", "title": "Educational Counseling in Improving Communication and Quality of Life in Spouses and Breast Cancer Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anxiety Disorder", "Depression", "Ductal Breast Carcinoma in Situ", "Lobular Breast Carcinoma in Situ", "Psychosocial Effects of Cancer and Its Treatment", "Stage IA Breast Cancer", "Stage IB Breast Cancer", "Stage II Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer" ], "interventions": [ { "name": "educational intervention", "type": "OTHER" }, { "name": "counseling intervention", "type": "OTHER" }, { "name": "psychosocial support for caregiver", "type": "OTHER" } ], "intervention_types": [ "OTHER" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 108, "start_date": "2009-03", "completion_date": "2014-12", "has_results": false, "last_update_posted_date": "2018-02-08", "last_synced_at": "2026-11-15T13:47:58.737Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01723943" } ] }